Home › Companies › KODIAK SCIENCES INC. › 2023-2024

KODIAK SCIENCES INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and KODIAK SCIENCES INC.’s Form 8-K, filed 2024-06-06 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 4Reported items
  • 138Asset managers
  • 762Fund votes
  • 2024-06-04Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore KODIAK SCIENCES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by KODIAK SCIENCES INC.

These tallies are KODIAK SCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

KODIAK SCIENCES INC. — official shareholder meeting results, meeting held 2024-06-04
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Felix J. Baker, Ph.D. 27,555,597---- 13,043,6714,251,142 Majority: yes
Elect Director: Victor Perlroth, M.D. 39,408,580---- 1,466,1943,975,636 Majority: yes
Proposal Two – Advisory Approval of the Compensation of Named Executive Officers . The compensation of the Company's named executive officers was approved, on an advisory basis, by the stockholders. 36,430,8784,405,09339,312 --3,975,127 Majority: yes

Source: KODIAK SCIENCES INC., Form 8-K, filed with the SEC on 2024-06-06 — read the filing on EDGAR.

How asset managers voted at the KODIAK SCIENCES INC. 2023-2024 meeting

Each item below shows how the 138 asset managers that disclosed a KODIAK SCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of KODIAK SCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%11%
FOR: 36,430,878AGAINST: 4,405,093

KODIAK SCIENCES INC.’s own tally for this item (“Proposal Two – Advisory Approval of the Compensation of Named Executive Officers . The compensation of the Company's named executive officers was approved, on an advisory basis, by the stockholders.”): 36,430,878 for, 4,405,093 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,523,447 outstanding shares: 69% for, 8% against (78% of the company cast a for/against vote).

The 137 asset managers below cast 86% of the shares they voted on this item FOR (33,429,025 for, 5,260,341 against).

FOR 86%14%
FOR: 33,429,025 (86.4%)AGAINST: 5,260,341 (13.6%)
Largest asset managers voting on “Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the prox” at KODIAK SCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BAKER BROS. ADVISORS LP17,310,4900 00For
BlackRock3,280,2690 00For
Vanguard1,714,1420 00For
EcoR1 Capital, LLC1,613,6000 00For
Invesco01,308,585 00Against
ICONIQ Capital, LLC01,016,864 00Against
Newtyn Management, LLC01,000,000 00Against
Fidelity960,0100 00For
TCG Crossover Management, LLC899,9990 00For
SILVERARC CAPITAL MANAGEMENT, LLC854,8050 00For
ACADIAN ASSET MANAGEMENT LLC818,5390 00For
State Street721,005113 00For
Board of Trustees of The Leland Stanford Junior University691,7670 00For
GEODE CAPITAL MANAGEMENT, LLC678,4610 00For
JACOBS LEVY EQUITY MANAGEMENT, INC576,2400 00For
Charles Schwab526,8200 00For
BRUCE FUND INC423,0000 00For
DE Shaw414,6100 00For
Dimensional0322,753 00Against
SEI0276,869 00Against
Goldman Sachs50271,540 00Against
Renaissance231,8150 00For
Hudson Bay Capital Management LP203,4550 00For
MELLON INVESTMENTS Corp164,2610 00For
Northern Trust147,3770 00For

Showing the 25 largest of 137 asset managers. See all 137 in the interactive database.

2. Elect two Class III directors nominated by our board and named in this proxy statement: Felix J. Baker, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%WITHHELD 32%
FOR: 27,555,597WITHHELD: 13,043,671

KODIAK SCIENCES INC.’s own tally for this item (“Elect Director: Felix J. Baker, Ph.D.”): 27,555,597 for, 13,043,671 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,523,447 outstanding shares: 52.5% for, 25% withheld (77% of the company cast a for/withheld vote).

The 51 asset managers below cast 100% of the shares they voted on this item FOR (2,902,840 for, 0 against).

FOR 43%ABSTAIN 57%
FOR: 2,902,840 (42.5%)ABSTAIN: 3,922,953 (57.5%)
Largest asset managers voting on “Elect two Class III directors nominated by our board and named in this proxy statement: Felix J. Baker, Ph.D.” at KODIAK SCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard1,656,4540 32,0000For
BlackRock00 1,615,7270Abstain
Fidelity782,8950 19,4970For
Invesco00 649,2550Abstain
BRUCE FUND INC423,0000 00For
Charles Schwab00 263,4100Abstain
Goldman Sachs00 206,1040Abstain
Dimensional00 191,3120Abstain
SEI00 138,3700Abstain
Equitable00 125,1750Abstain
BRIDGEWAY FUNDS INC00 114,2000Abstain
Nationwide00 79,3060Abstain
QUANTITATIVE MASTER SERIES LLC00 58,8520Abstain
TIAA00 53,9470Abstain
American Century00 46,4110Abstain
MFS00 46,2230Abstain
TARGET PORTFOLIO TRUST38,2000 00For
Columbia Threadneedle00 33,5100Abstain
Lincoln Financial00 28,1700Abstain
Thrivent00 19,2080Abstain
Putnam00 16,2200Abstain
AIG/SunAmerica00 15,9840Abstain
State Street00 13,8590Abstain
Pacific Life00 13,7810Abstain
Bridge Builder Trust00 13,6970Abstain

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

3. Elect two Class III directors nominated by our board and named in this proxy statement: Victor Perlroth, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 39,408,580WITHHELD: 1,466,194

KODIAK SCIENCES INC.’s own tally for this item (“Elect Director: Victor Perlroth, M.D.”): 39,408,580 for, 1,466,194 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 52,523,447 outstanding shares: 75% for, 3% withheld (78% of the company cast a for/withheld vote).

The 51 asset managers below cast 100% of the shares they voted on this item FOR (6,615,972 for, 0 against).

FOR 97%
FOR: 6,615,972 (96.9%)ABSTAIN: 209,821 (3.1%)
Largest asset managers voting on “Elect two Class III directors nominated by our board and named in this proxy statement: Victor Perlroth, M.D.” at KODIAK SCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard1,688,4540 00For
BlackRock1,615,7270 00For
Fidelity802,3920 00For
Invesco649,2550 00For
BRUCE FUND INC423,0000 00For
Charles Schwab263,4100 00For
Goldman Sachs206,1040 00For
Dimensional00 191,3120Abstain
SEI138,3700 00For
Equitable125,1750 00For
BRIDGEWAY FUNDS INC114,2000 00For
Nationwide79,3060 00For
QUANTITATIVE MASTER SERIES LLC58,8520 00For
TIAA53,9470 00For
American Century46,4110 00For
MFS46,2230 00For
TARGET PORTFOLIO TRUST38,2000 00For
Columbia Threadneedle33,5100 00For
Lincoln Financial27,0150 1,1550For
Thrivent19,2080 00For
Putnam16,2200 00For
AIG/SunAmerica15,9840 00For
State Street13,8590 00For
Pacific Life13,7810 00For
Bridge Builder Trust13,6970 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

4. Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2024.

AUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 99.9% of the shares they voted on this item FOR (6,825,632 for, 161 against).

FOR: 6,825,632 (100.0%)AGAINST: 161 (0.0%)
Largest asset managers voting on “Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for ” at KODIAK SCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard1,688,4540 00For
BlackRock1,615,7270 00For
Fidelity802,3920 00For
Invesco649,2550 00For
BRUCE FUND INC423,0000 00For
Charles Schwab263,4100 00For
Goldman Sachs206,1040 00For
Dimensional191,3120 00For
SEI138,3700 00For
Equitable125,1750 00For
BRIDGEWAY FUNDS INC114,2000 00For
Nationwide79,3060 00For
QUANTITATIVE MASTER SERIES LLC58,8520 00For
TIAA53,9470 00For
American Century46,4110 00For
MFS46,2230 00For
TARGET PORTFOLIO TRUST38,2000 00For
Columbia Threadneedle33,5100 00For
Lincoln Financial28,1700 00For
Thrivent19,2080 00For
Putnam16,2200 00For
AIG/SunAmerica15,9840 00For
State Street13,8590 00For
Pacific Life13,7810 00For
Bridge Builder Trust13,6970 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

Largest KODIAK SCIENCES INC. shareholders voting in 2023-2024

Ranked by the number of KODIAK SCIENCES INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 52,523,447 shares outstanding at the time of that meeting.

Top KODIAK SCIENCES INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1BAKER BROS. ADVISORS LP 32.96%
2BlackRock 6.25%
3Vanguard 3.26%
4EcoR1 Capital, LLC 3.07%
5Invesco 2.49%
6ICONIQ Capital, LLC 1.94%
7Newtyn Management, LLC 1.90%
8Fidelity 1.83%
9TCG Crossover Management, LLC 1.71%
10SILVERARC CAPITAL MANAGEMENT, LLC 1.63%

Reported KODIAK SCIENCES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

KODIAK SCIENCES INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
Felix J. Baker, Ph.D. 33.09% DEF14A
Entities affiliated with Baker Bros. Advisors LP 32.96% DEF14A
Victor Perlroth, M.D. 15.11% DEF14A
D. Victor Perlroth, M.D. 10.96% 13G
Entities affiliated with BlackRock, Inc. 7.68% DEF14A
BlackRock 5.62% 13F
Vanguard Group 3.71% 13F
D.E. Shaw 1.99% 13F
John A. Borgeson 1.83% DEF14A
State Street 1.42% 13F

Percentages above are of 52,523,447 shares outstanding, as reported by KODIAK SCIENCES INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from KODIAK SCIENCES INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At KODIAK SCIENCES INC.'s shareholder meeting held 2024-06-04, in the 2023-2024 proxy season, 138 asset managers reported how they voted in their SEC Form N-PX filings, covering 762 separate fund positions. Their filings are grouped here into 4 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as… — FOR was 89% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: KODIAK SCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-06.

KODIAK SCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.